Literature DB >> 9051104

Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.

B Galvão-Castro, L Loures, L G Rodriques, A Sereno, O C Ferreira Júnior, L G Franco, M Muller, D A Sampaio, A Santana, L M Passos, F Proietti.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9051104     DOI： 10.1046/j.1537-2995.1997.37297203532.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  44 in total

1.  Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Authors:  T Luna; S B Santos; M Nascimento; M A F Porto; A L Muniz; E M Carvalho; A R Jesus
Journal:  Braz J Med Biol Res       Date:  2011-10-22       Impact factor: 2.590

2.  Study of autoantibodies in patients with keratoconjunctivitis sicca infected by the human T cell lymphotropic virus type 1.

Authors:  Ana Karina Ferraz-Chaoui; Ajax Mercês Atta; Maria Luiza Sousa Atta; Bernardo Galvão-Castro; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2009-07-29       Impact factor: 2.631

3.  Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.

Authors:  Rita Elizabeth Mascarenhas; Cláudia Brodskyn; Geisa Barbosa; Jorge Clarêncio; Antônio Souza Andrade-Filho; Frederico Figueiroa; Bernardo Galvão-Castro; Fernanda Grassi
Journal:  Clin Vaccine Immunol       Date:  2006-05

4.  Impact of depression on quality of life in people living with human T cell lymphotropic virus type 1 (HTLV-1) in Salvador, Brazil.

Authors:  Ana Verena Galvão-Castro; Ney Boa-Sorte; Ramon Almeida Kruschewsky; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro
Journal:  Qual Life Res       Date:  2011-11-23       Impact factor: 4.147

Review 5.  Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases.

Authors:  Denise Utsch Gonçalves; Fernando Augusto Proietti; João Gabriel Ramos Ribas; Marcelo Grossi Araújo; Sônia Regina Pinheiro; Antônio Carlos Guedes; Anna Bárbara F Carneiro-Proietti
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

6.  The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.

Authors:  Fabianna Bahia; Vinicius Novais; Jennifer Evans; Chloe Le Marchand; Eduardo Netto; Kimberly Page; Carlos Brites
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

7.  Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.

Authors:  Luis Chandía; Cristina Sotomayor; Sylvia Ordenes; Pilar Salas; Maritza Navarrete; Mauricio Lopez; Carola Otth
Journal:  Med Microbiol Immunol       Date:  2010-08-13       Impact factor: 3.402

8.  Clinical manifestations in individuals with recent diagnosis of HTLV type I infection.

Authors:  Shelene K W Poetker; Aurelia F Porto; Silvana P Giozza; Andre L Muniz; Marina F Caskey; Edgar M Carvalho; Marshall J Glesby
Journal:  J Clin Virol       Date:  2011-03-08       Impact factor: 3.168

9.  HTLV-1 modifies the clinical and immunological response to schistosomiasis.

Authors:  A F Porto; S B Santos; L Alcantara; J B Guerreiro; J Passos; T Gonzalez; F Neva; D Gonzalez; J L Ho; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Infective dermatitis has similar immunological features to human T lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  M C F Nascimento; J Primo; A Bittencourt; I Siqueira; M de Fátima Oliveira; R Meyer; A Schriefer; S B Santos; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.